Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα ...
Jan 13, 2025 · INDIANAPOLIS and BOSTON, Mass., Jan. 13, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Scorpion Therapeutics, Inc. ("Scorpion"), a private biotechnology …
Eli Lilly to acquire cancer program from Scorpion Therapeutics
Jan 13, 2025 · SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company …
Lilly inks $2.5B Scorpion buyout in twist to breast cancer tale
Jan 13, 2025 · Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion …
Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to …
Jan 13, 2025 · Eli Lilly said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of cancer treatments.
Eli Lilly targets Scorpion Therapeutics to expand reach in oncology
Jan 14, 2025 · After selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a different entity, which will be owned by the biotech’s current shareholders.
Eli Lilly To Buy Scorpion Therapeutics' Experimental Cancer …
Jan 13, 2025 · (RTTNews) - Eli Lilly and Company (LLY) on Monday said it has agreed to buy Scorpion Therapeutics' experimental cancer therapy PI3Ka inhibitor program STX-478 for up …
Lilly Drops Up to $2.5B for Scorpion’s PI3K-inhibitor Molecule
Jan 13, 2025 · There’s been no shortage of blockbuster deals as the J.P. Morgan Healthcare Conference kicked off Monday in San Francisco, and now Eli Lilly has joined the fray, setting …
Eli Lilly scientific chief Skovronsky says Scorpion deal ... - STAT
Jan 13, 2025 · SAN FRANCISCO — Eli Lilly’s chief scientific officer said Monday that the company purchased a cancer drug from the startup Scorpion Therapeutics because …
Lilly nets Scorpion cancer drug in $2.5bn licensing deal
Jan 13, 2025 · Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of …
Lilly acquires Scorpion Therapeutics in deal worth up to $2.5B
Jan 14, 2025 · Eli Lilly and Co. announced Monday that it is buying Boston-based Scorpion Therapeutics and its targeted breast cancer treatment program in a deal worth up to $2.5 billion.
- Some results have been removed